TIFCEMALIMAB
UNII D40H7X1YZ0

Substance Identification & Data

This profile provides standardized clinical and technical data for Tifcemalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D40H7X1YZ0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2236068-83-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D40H7X1YZ0

CAS Registry Number

2236068-83-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TIFCEMALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C168617

National Cancer Institute reference terminology for clinical and research data.

INN ID

11192

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tifcemalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TIFCEMALIMAB

Common Names & Synonyms

ANTI-BTLA MONOCLONAL ANTIBODY TAB004

ICATOLIMAB

IMMUNOGLOBULIN G4, ANTI-(HUMAN B AND T LYMPHOCYTE ATTENUATOR (BTLA)) (HUMAN-MUS MUSCULUS MONOCLONAL JS004 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL JS004 .KAPPA.-CHAIN, DIMER

TIFCEMALIMAB [INN]

TIFCEMALIMAB [WHO-DD]